Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

36.144 (0.049%)
NAV on September 12, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,309 cr
Turnover Ratio 11.18%
Expense Ratio 0.62%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 1.20%
  • 1Y: 0.02%
  • 3M: 3.82%
  • 3Y: 25.37%
  • 6M: 13.77%
  • 5Y: 21.24%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since 12 months)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 38.90
P/B Ratio 5.96
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 4.38
Beta 0.94
R-Squared 96.36
Info Ratio 1.35
Tracking Err 3.23
Sortino 1.951
Sharpe 1.079
Std Dev 15.970
Risk -
SECTOR WEIGHTINGS (%)
Financial 1.6%
Industrial 0.0%
Technology 0.0%
Basic Materials 1.48%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 96.92%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Sbi
SBI Healthcare Opportunities Fund Direct Growth
499.060 5.50% 3,963 cr 0.91% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund